Rankings
▼
Calendar
TARS FY 2019 Earnings — Tarsus Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
TARS
Tarsus Pharmaceuticals, Inc.
$3B
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$74,000
Operating Income
-$4M
Net Income
-$5M
EPS (Diluted)
$-0.24
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$18,000
Balance Sheet
Total Assets
$58M
Total Liabilities
$64M
Stockholders' Equity
-$6M
Cash & Equivalents
$58M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$74,000
-$1,000
-7300.0%
Operating Income
-$4M
-$1M
-218.4%
Net Income
-$5M
-$1M
-254.1%
← FY 2018
All Quarters
Q3 2019 →